Silence Therapeutics plc SLN

$ 6.96 9.7%

Annual report 2023
added 12-21-2024

Silence Therapeutics plc Financial Statements 2011-2024 | SLN

Annual Financial Statements Silence Therapeutics plc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	1.63 B	632 M	-	-	-	-	52.9 M	-	-	-	-
Shares	-	-	89 M	25 M	-	-	-	-	21.3 M	-	-	-	-
Historical Prices	21.9	6.99	18.3	25.2	-	-	-	-	-	-	-	-	-
Net Income	-	-	-39.4 M	-22.1 M	-19.6 M	-18.4 M	-1.62 M	-8.44 M	-6.64 M	-11.1 M	-9 M	-26.3 M	-5.74 M
Revenue	-	-	-	5.3 M	244 K	-	16 K	770 K	-	15 K	117 K	163 K	694 K
Cost of Revenue	-	-	7.46 M	3.76 M	-	-	-	-	-	-	-	-	-
Gross Profit	15.1 M	6.62 M	4.96 M	1.72 M	244 K	-	-	-	-7.11 M	-8.87 M	-5.53 M	-3.22 M	-2.67 M
Operating Income	-	-	-45.8 M	-35.8 M	-22.7 M	-20.6 M	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-45.8 M	-35.8 M	-22.7 M	-20.6 M	-14 M	-11.6 M	-9.59 M	-11.8 M	-8.7 M	-5.31 M	-5.02 M
Operating Expenses	-	-	-	-	-	-	-	-	2.66 M	3.26 M	3.54 M	2.34 M	2.65 M
General and Administrative Expenses	-	-	20 M	10.3 M	9.64 M	10.8 M	6.46 M	3.96 M	2.66 M	3.26 M	3.54 M	2.61 M	2.65 M

All numbers in GBP currency

Quarterly Income Statement Silence Therapeutics plc

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency